ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

In Brief: Shannn Award Selections Made; ACS Funds 431 Grants Worth $50 Mil.; 500 Nurses Pass Exam

August 30, 1991

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

MSKCC Wins Zoning Request For New Labs.

February 8, 2002

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007